Innate Pharma (IPHA) Amortization - Intangibles (2020 - 2022)
Innate Pharma (IPHA) posted quarterly Amortization - Intangibles of -$46656.1 for Q4 2022, up 99.91% on a QoQ basis from -$49.5 million in Q4 2020.
Innate Pharma (IPHA) Amortization - Intangibles (2020 - 2022) Analysis & Trends
Innate Pharma (IPHA) has reported Amortization - Intangibles for 2 consecutive years, with -$46656.1 the latest figure, recorded in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innate Pharma | 157.68 Mn | 157.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -46,656.13 |
| Dec 31, 2020 | -49.53 Mn |